Antibodies - Move COVID-19 research forward with Simoa® ultra-sensitive cytokine detection
Can't see this email? View it online
   
  Antibodies  
  The latest antibodies news from News Medical  
 

VHH Antibodies (Nanobodies) Advantages and LimitationsImproving SARS-CoV-2 Antibody Detection with Bioluminescence

The Lumit™ Dx SARS-CoV-2 Immunoassay is an IVD test designed to qualitatively detect antibodies to SARS-CoV-2 in serum or plasma. The bioluminescent method used in the assay provides clinical labs with a simple, scalable workflow that is easily automated, taking you from sample to answer in 1 hour.

Find Out More
 
 
    Keysight Move COVID-19 research forward with Simoa® ultra-sensitive cytokine detection
 
Recent evidence suggests cytokine imbalances may fail to clear SARS-CoV-2 infection and induce protection against reinfection. With Simoa SP-X, measuring cytokines at 10-100x lower levels enables robust quantification of healthy baselines and early rises of cytokines in order to:
  • Identify predictive biomarkers of disease severity
  • Monitor disease progression
  • Determine Th1/Th2 balance
  • Evaluate therapeutic impacts on inflammatory response
  • Quantify low abundance cytokines
  • Quantify medium- to high-abundance cytokines in low and highly diluted sample volumes
Learn More
 
 
   Monoclonal Antibodies: Discovery, Characterization and ChallengesMonoclonal Antibodies: Discovery, Characterization and Challenges
 
In this interview, News-Medical talks to David Apiyo, a senior manager of applications at Sartorius AG, about monoclonal antibody development and characterization.
 
 Fluorescent Antibody Techniques
 
Fluorescent Antibody TechniquesSince its original discovery, immunofluorescence staining has remained a reliable and powerful technique for a wide range of research and diagnostic purposes.
 
 
 New study reports on extremely potent human monoclonal antibodies for SARS-CoV-2
 
New study reports on extremely potent human monoclonal antibodies for SARS-CoV-2Researchers have recovered and identified the various types of neutralizing antibodies for SARS-CoV-2 from convalescent COVID-19 patients. Of these, they identified three that are extremely potent and could be used to develop treatment therapies.
 
 
 Study shows antibody levels drop rapidly in recovering COVID-19 patients
 
Study shows antibody levels drop rapidly in recovering COVID-19 patientsThe lack of effective treatments for COVID-19 is forcing hospitals to use blood plasma from recovering patients to treat those who have severe symptoms.
 
 
 Study shows lasting immunity offered by SARS-CoV-2 antibodies
 
Study shows lasting immunity offered by SARS-CoV-2 antibodiesOne of the most significant questions about the novel coronavirus is whether people who are infected are immune from reinfection and, if so, for how long.